Celebrate the MPN Heroes in Your Life!
Join us to honor the MPN Heroes in your life as we celebrate the ten-year anniversary of the MPN Heroes® Recognition Program in 2022. Since 2013, the program has recognized the people and organizations that have dedicated themselves to improving the lives of people with myeloproliferative neoplasms, or MPNs. The program focuses on the three "classical" MPNs—or what are known as Philadelphia chromosome–negative MPNs.
Created in the spirit of fostering community, the MPN Heroes Recognition Program recognizes patients, Healthcare Professionals, caregivers, advocates, and organizations that bring understanding, compassion, and strength to the MPN community.
The MPN Heroes Recognition Program, is sponsored by Incyte Corporation and CURE magazine. The goal of the program is to create as many opportunities as possible for people with MPNs to be heard and to be supported, so more solutions and treatment options will emerge.
Who Is an MPN Hero?
Thank you to all who participated in the 2022 MPN Heroes Recognition Program by nominating someone who has made a difference in MPN care. Your hero may be any of the following:
- Patient whose strength has inspired you
- Caregiver who has consistently offered you support and reassurance
- Healthcare Professional who has listened to you and treated you with compassion
- Organization or institution dedicated to improving MPN care and support
When Is the MPN Heroes Celebration Event?
The 2022 MPN Heroes Celebration Event, hosted by CURE Media Group, will take place on December 9, 2022.
Who Are the Sponsors of the MPN Heroes Recognition Program?
MPN Heroes is a program sponsored by Incyte Corporation and CURE magazine.
What Are the Rules for the 2022 MPN Heroes Recognition Program?
The MPN Heroes Program recognizes dedication to individuals and the MPN community. Individuals or organizations are nominated in one of two categories. Recipients are selected by a judging panel's review of nominations for recognition. Members of the judging panel receive honoraria for their service. In Category A, up to four recognition plaques are given to chosen recipients, and in Category B, up to four monetary donations to non-profit organizations and societies are given in recognition of the four recipients recognized in this category. Incyte makes monetary donations to select non-profit 501(c)(3), US-based organizations or societies that improve the lives of individuals with MPNs.
Criteria for nominations in either category are as follows:
- Choose only one category for the nominee to be considered
- Clearly state the MPN (MF, PV, or ET) patient need being addressed
- A completed nomination form must be submitted by September 8, 2022
- The achievements of the organization or individual must be recent (ie, should have taken place within the last 24 months)
- Organizations may submit an entry for their own program, but it must be for one specific activity or program and only one entry per year, and we strongly encourage independent confirmation
- Individuals can be recognized posthumously
- Institutions, organizations, or individuals can be nominated by themselves or by others, but they must be aware of the nomination, and the nomination must be approved by, and compliant with, any institutional rules and guidelines
Criteria: Category A: Commitment to the individual. Recognizing individuals who provide or demonstrate care, guidance, education, or support above and beyond the standard of care for one or more patients with MPNs. Types of work honored include demonstration of individual dedication by a nurse, Healthcare Professional, or caregiver whose contributions to an individual with an MPN had an evident impact.
Criteria: Category B: Commitment to the broader MPN community. Recognizing leadership in developing services or programs addressing the needs of patients with MPNs, families, friends, caregivers, and medical professionals through advancing the science and medical understanding of MPNs, education, awareness, or approaches to care.
Types of work honored could include advocating for better care, outreach to underserved populations, activities at the grassroots level, promoting the patient’s voice, providing MPN community leadership, creating awareness programs, innovative education materials, programs, or events, disease management initiatives, research and science-based programs, media outreach, or campaigns.
- Employees or agents of Incyte, VOZ Advisors, or other Incyte vendors and members of their immediate family as well as current program year judging panel members are not eligible for recognition
- Nominated individuals, institutions, or organizations and the programs or activities nominated must originate and be executed in one or more of the 50 states of the United States, the District of Columbia, or Puerto Rico
- Nominated programs must be independent of purchase, use, and prescribing for any Incyte product
- The following are ineligible for recognition:
- Programs or activities that Incyte provided grants or other funding for directly
- Political lobbying activities
- Medical research or publications that have been funded or directed by Incyte
- Any nominee whose organization or institution does not allow recognition in the manner set forth in this program
- Nominated individuals or organizations must serve or be involved with the myelofibrosis (MF), polycythemia vera (PV), or essential thrombocythemia (ET) communities
- Judging panel reserves the right to exclude nominations of individuals for any perceived conflict of interest
- Individuals or organizations may not be recognized two years in a row or for a length of time agreed upon by the judging panel. Click here to view past Heroes